Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 105,690 $ 125,492
Marketable securities 14,973 2,979
Restricted cash 3,591  
Accounts receivable, net 34,233 42,241
Inventories, net 23,320 21,840
Income tax receivable 964 669
Prepaid expenses and other current assets 9,783 13,846
Total current assets 192,554 207,067
Property and equipment, net 46,598 50,316
Goodwill 10,170 10,057
Intangible assets, net 33,762 34,591
Operating lease right-of-use asset 19,017 20,338
Other assets 4,071 3,825
Total assets 306,172 326,194
Current liabilities    
Accounts payable and accrued expenses 27,028 30,142
Accrued payroll 14,285 11,066
Warranty reserve - current 9,492 9,628
Operating lease liability - current 2,777 3,653
Earnout liability 11,830 10,000
Deferred revenue - current 6,984 7,980
Income tax payable   27
Total current liabilities 72,396 72,496
Long-term liabilities    
Warranty reserve - noncurrent 16,183 13,850
Operating lease liability - noncurrent 17,370 18,270
Deferred revenue - noncurrent 6,435 8,227
Deferred tax liability 8,384 8,539
Total liabilities 120,768 121,382
Commitments and contingencies (Note 10)
Stockholders' equity    
Common stock, $0.001 par value per share; 200,000,000 authorized; 23,817,704 and 23,324,750 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 24 23
Additional paid-in capital 326,741 320,513
Accumulated deficit (143,080) (116,949)
Accumulated other comprehensive income 1,719 1,225
Total stockholders' equity 185,404 204,812
Total liabilities and stockholders' equity $ 306,172 $ 326,194